Publication: Circ_0079530 stimulates THBS2 to promote the malignant progression of non-small cell lung cancer by sponging miR-584-5p
Authors
Fang, Kun ; Deng, Yibin ; Yang, Ping ; Zhang, Yurong ; Luo, Dan ; Wang, Fang ; Cai, Zhilong ; Liu, Yang
item.page.secondaryauthor
item.page.director
Publisher
Universidad de Murcia, Departamento de Biologia Celular e Histiologia
publication.page.editor
publication.page.department
DOI
https://doi.org/10.14670/HH-18-545
item.page.type
info:eu-repo/semantics/article
Description
Abstract
Background. Circ_0079530 has been
confirmed to be a novel potential oncogene in non-small
cell lung cancer (NSCLC). This study aims to explore
the role and mechanism of circ_0079530 in NSCLC
progression.
Methods. Levels of circ_0079530, microRNA
(miR)-584-5p, thrombospondin-2 (THBS2), PCNA,
Bax, E-cadherin, and ki67 were detected by quantitative
real-time PCR (qRT-PCR), western blotting and
immunohistochemistry. The proliferation of NSCLC
cells was measured using cell counting kit 8 (CCK8)
assay, colony formation assay, and EdU staining. Cell
apoptosis and motility were respectively detected by
flow cytometry and transwell assays. Interaction
between miR-584-5p and circ_0079530 or THBS2 was
predicted by bioinformatics analysis and confirmed via
luciferase reporter assay and RNA immunoprecipitation
(RIP) assay. A xenograft tumor model was used to
analyze the role of circ_0079530 in tumor growth in
vivo.
Results. Circ_0079530 was highly expressed in
NSCLC tissues and cell lines. Circ_0079530
overexpression facilitated proliferation, migration, and
invasion whereas it restrained the apoptosis of NSCLC
cells. Circ_0079530 silence showed the opposite effects
on the above malignant biological behaviors.
Mechanistic analysis showed that circ_0079530
functioned as a sponge of miR-584-5p to relieve the
suppressive action of miR-584-5p on its target THBS2.
Additionally, circ_0079530 knockdown impeded the
growth of xenografts in vivo.
Conclusion. Circ_0079530 promoted NSCLC
progression by regulating the miR-584-5p/THBS2 axis,
providing a possible circRNA-targeted therapy for
NSCLC.
publication.page.subject
Citation
Histology and Histopathology Vol. 38, nº6 (2023)
item.page.embargo
Ir a EstadÃsticas
Este Ãtem está sujeto a una licencia Creative Commons. http://creativecommons.org/licenses/by-nc-nd/4.0/